移至標頭移至導覽移至內部移至註腳

研究成果 (55)

排序依據：日期 | 題名

10 | 25 | 50 | 100

上一頁

上一頁

1/6

下一頁

最後一頁

A B C D E F G H I M N O P Q R S T U W 全部

Accomplishments in 2007 in the management of hepatobiliary cancers
CHAN Anthony Tak Cheung, KISHI Y, CHAN Lam Stephen, VAUTHEY J N ( 2008 )
Gastrointest Cancer Res
Publication in refereed journal
A comparison of three transarterial Lipiodol-based formulations for hepatocellular carcinoma: In vivo biodistribution study in humans
Yu SCH, Leung TWT, Lau WY, Lee N, Hui EP, Yeo W, Lai PBS, Mok TSK ( 2008 )
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s00270-007-9173-8
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine (R)) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Ma B, Goh BC, Tan EH, Lam KC, Soo R, Leong SS, Wang LZ, Mo F, Chan ATC, Zee B, Mok T ( 2008 )
INVESTIGATIONAL NEW DRUGS
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s10637-007-9085-0
A novel application of plasma and cerebrospinal fluid level of Epstein Barr virus DNA in the diagnosis of leptomeningeal metastasis from nasopharyngeal carcinoma
Ma ATW, Ma BBY, Teo PML, Chan ATC ( 2008 )
ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1159/000139140
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy
Ma B, Hui EP, King A, To KF, Mo F, Leung SF, Kam M, Lo YMD, Zee B, Mok T, Ahuja A, Chan ATC ( 2008 )
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s00280-007-0575-8
A Prognostic Model for The Combined Analysis of Gene Expression Profiling in Hepatocellular Carcinoma
ZEE Chung Ying Benny, LEE Jock Wai, WONG Nathalie, YEO Winnie, LAI Bo San Paul, MOK Shu Kam Tony, CHAN Anthony Tak Cheung ( 2008 )
Bioinformation
Publication in refereed journal
A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma
Chau RMC, Leung SF, Kam MKM, Cheung KY, Kwan WH, Yu KH, Chiu SKW, Chan ATC ( 2008 )
CLINICAL ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.clon.2007.10.006
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals
Zhu JQ, Zhong WZ, Zhang GC, Li R, Zhang XC, Guo AL, Zhang YF, An SJ, Mok TS, Wu YL ( 2008 )
CANCER LETTERS
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.canlet.2008.02.064
CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients
Lin XR, Gudgeon NH, Hui EP, Jia H, Qun X, Taylor GS, Barnardo MCNM, Lin CK, Rickinson AB, Chan ATC ( 2008 )
CANCER IMMUNOLOGY IMMUNOTHERAPY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s00262-007-0427-8
Clinical encounter experiences of patients with nasopharyngeal carcinoma
Lee EWC, Twinn S, Moore AP, Jones MP, Leung SF ( 2008 )
INTEGRATIVE CANCER THERAPIES
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1177/1534735407313448

10 | 25 | 50 | 100

上一頁

上一頁

1/6

下一頁

最後一頁